207 related articles for article (PubMed ID: 26423143)
21. Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.
Fagot JP; Blotière PO; Ricordeau P; Weill A; Alla F; Allemand H
Diabetes Care; 2013 Feb; 36(2):294-301. PubMed ID: 22966091
[TBL] [Abstract][Full Text] [Related]
22. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
[TBL] [Abstract][Full Text] [Related]
23. Attitudes of community pharmacists to off-label prescribing of baclofen in Northern France.
Auffret M; Rolland B; Caous AS; Deheul S; Béné J; Cottencin O; Bordet R; Gautier S
Int J Clin Pharm; 2015 Apr; 37(2):296-9. PubMed ID: 25666941
[TBL] [Abstract][Full Text] [Related]
24. [Baclofen: when does one know the scientific truth about its effectiveness in alcoholic disease?].
Nau JY
Rev Med Suisse; 2015 Sep; 11(485):1674-5. PubMed ID: 26540999
[No Abstract] [Full Text] [Related]
25. [Comparing results of methicillin-resistant Staphylococcus aureus (MRSA) surveillance using the French DRG-based information system (PMSI)].
Nuemi G; Astruc K; Aho S; Quantin C
Rev Epidemiol Sante Publique; 2013 Oct; 61(5):455-61. PubMed ID: 23993689
[TBL] [Abstract][Full Text] [Related]
26. Cohort of one million patients initiating antidepressant treatment in France: 12-month follow-up.
Fagot JP; Cuerq A; Samson S; Fagot-Campagna A
Int J Clin Pract; 2016 Sep; 70(9):744-51. PubMed ID: 27484351
[TBL] [Abstract][Full Text] [Related]
27. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
[TBL] [Abstract][Full Text] [Related]
28. Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation.
Rolland B; Labreuche J; Duhamel A; Deheul S; Gautier S; Auffret M; Pignon B; Valin T; Bordet R; Cottencin O
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1631-6. PubMed ID: 26095229
[TBL] [Abstract][Full Text] [Related]
29. [Involvement of pharmacists in systems for supervising off-label medications: example of the CAMTEA system for the prescription of baclofen in alcohol use disorder in Northern France].
Auffret M; Rolland B; Deheul S; Lecomte L; Cottencin O; Bordet R; Gautier S;
Ann Pharm Fr; 2014 Jan; 72(1):28-32. PubMed ID: 24438666
[TBL] [Abstract][Full Text] [Related]
30. Incidence of Orbital Exenteration: A Nationwide Study in France over the 2006-2017 Period.
Martel A; Nahon-Esteve S; Gastaud L; Bertolotto C; Lassalle S; Baillif S; Charles A
Ophthalmic Epidemiol; 2021 Apr; 28(2):169-174. PubMed ID: 32693661
[TBL] [Abstract][Full Text] [Related]
31. A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.
Auffret M; Rolland B; Béhal H; Labreuche J; Jouanjus E; Bordet R; Gautier S
Therapie; 2019 Dec; 74(6):645-650. PubMed ID: 31277890
[TBL] [Abstract][Full Text] [Related]
32. Evolution of general practitioners' preferences for antipsychotics in France, 2003-2010.
Gallini A; Gardette V; Oumouhou N; Andrieu S; Donohue JM
Psychiatr Serv; 2015 Apr; 66(4):434-7. PubMed ID: 25588416
[TBL] [Abstract][Full Text] [Related]
33. Agreement between hospital discharge diagnosis codes and medical records to identify metastatic colorectal cancer and associated comorbidities in elderly patients.
Gouverneur A; Dolatkhani D; Rouyer M; Grelaud A; Francis F; Gilleron V; Fourrier-Réglat A; Noize P
Rev Epidemiol Sante Publique; 2017 Aug; 65(4):321-325. PubMed ID: 28576381
[TBL] [Abstract][Full Text] [Related]
34. [Use of the PMSI for the detection of adverse drug reactions].
Osmont MN; Cuggia M; Polard E; Riou C; Balusson F; Oger E
Therapie; 2013; 68(4):285-95. PubMed ID: 23981266
[TBL] [Abstract][Full Text] [Related]
35. [Impact of the estimation of the medically insured population on the pharmacological prevalence of diabetes at the regional and small area level].
Jardin M; Bocquier A; Nauleau S; Millon C; Verger P
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):159-67. PubMed ID: 19403251
[TBL] [Abstract][Full Text] [Related]
36. The state of pharmacotherapy for the treatment of alcohol dependence.
Garbutt JC
J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
[TBL] [Abstract][Full Text] [Related]
37. [Perinatal health and medical administrative data: What uses, which stakeholders, what the issues for birth data? - Special REDSIAM].
Serfaty A; Baron S; Crenn-Hebert C; Barry Y; Tala S
Rev Epidemiol Sante Publique; 2017 Oct; 65 Suppl 4():S209-S219. PubMed ID: 28847678
[TBL] [Abstract][Full Text] [Related]
38. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
39. [Drug prescriptions: an epidemiological survey of French general practitioners].
Durieux P
Presse Med; 2000 Jun; 29(20):1126-7. PubMed ID: 10901792
[No Abstract] [Full Text] [Related]
40. [A system of prescriptions without drug approval: example of baclofen].
Rolland B; Deheul S; Danel T; Bordet R; Cottencin O
Therapie; 2010; 65(6):511-8. PubMed ID: 21176757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
